Stocks · Healthcare · Medical - Devices
Avita Medical Inc. RCEL
$12.72 +5.91% Close, Oct 2, 2026 · NASDAQ · Market cap $316.0M
Strong trendHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -46.6% from -62.4% a year earlier.
- The diluted share count rose 16.6% in a year.
- Over the past year the stock returned +142.3%, ahead of the S&P 500 by 127.2 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 31%
- Revenue growth, 3-year CAGRTop 23%
- Revenue growth accelerationTop 44%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 6%
- Gross marginTop 29%
- Operating marginBottom 35%
- Accruals (lower is better)Top 5%
- Interest coverBottom 38%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 43%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueBottom 40%
- Sales / enterprise valueBottom 50%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 16%
- 6-month returnTop 2%
- 1-year return vs S&P 500Top 9%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 43%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 31%
- Upside to consensus price targetBottom 6%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 4%
- Maximum drawdown, 3 yearsBottom 28%
- Beta vs S&P 500 (lower is better)Bottom 15%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1.0% | 1.0% | ↑ |
| Gross margin | 84.3% | 81.6% | ↓ |
| Operating margin | -62.4% | -46.6% | ↑ |
| FCF margin | -56.1% | -31.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 1.0% | 1.0% | ↑ | Bottom 31% |
| Gross margin | 81.6% | 84.3% | ↓ | Top 29% |
| Operating margin | -46.6% | -62.4% | ↑ | Bottom 35% |
| Net margin | -57.0% | -68.9% | ↑ | — |
| Free-cash-flow margin | -31.2% | -56.1% | ↑ | — |
| Return on invested capital | -136.9% | — | Bottom 6% | |
| Revenue growth, 3-year CAGR | 27.7% | — | Top 23% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -39.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 9.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -16.3 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -6.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -4.44%
- Shareholder yield
- -4.44%
- Share count change, 1 year
- +16.6%
- Share count change, 3-year CAGR
- +6.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- +0.8%
- Average 2-day reaction, last 8
- +0.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $11.50
- Target vs current price
- -9.6%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +14.6% | +6.3% | +81.7% | +140.7% | — |
| May 14, 2026 | +0.0% | +2.3% | +1.4% | -6.8% | +78.4% |
| Feb 12, 2026 | -4.3% | -3.1% | +14.1% | +19.3% | +7.0% |
| Nov 6, 2025 | -7.0% | -2.9% | +8.0% | +1.4% | +22.9% |
| Aug 7, 2025 | -46.2% | +0.4% | +7.5% | -20.0% | -31.5% |
| May 8, 2025 | -35.9% | -1.5% | -29.4% | -39.3% | -43.5% |
| Feb 13, 2025 | -46.7% | +2.0% | +15.6% | -3.5% | -19.0% |
| Nov 7, 2024 | -47.6% | +1.7% | +5.6% | +2.1% | -22.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.25 | -$0.29 | +14.6% | $21.5M |
| May 14, 2026 | -$0.35 | -$0.35 | +0.0% | $19.3M |
| Feb 12, 2026 | -$0.38 | -$0.36 | -4.3% | $17.4M |
| Nov 6, 2025 | -$0.46 | -$0.43 | -7.0% | $17.1M |
| Aug 7, 2025 | -$0.38 | -$0.26 | -46.2% | $12.0M |
| May 8, 2025 | -$0.53 | -$0.39 | -35.9% | $11.6M |
| Feb 13, 2025 | -$0.44 | -$0.30 | -46.7% | $11.4M |
| Nov 7, 2024 | -$0.62 | -$0.42 | -47.6% | $13.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 4.70× | — | — | Bottom 50% |
| Free-cash-flow yield | -7.47% | — | — | Bottom 43% |
| Earnings yield | -11.40% | — | — | Bottom 43% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 57
- Days above the 200-day average
- 57
- 50-day average slope (20 days)
- +39.6%
- 200-day average slope (20 days)
- +15.7%
- Distance from 50-day average
- +39.3%
- Distance from 200-day average
- +132.7%
- RSI (14)
- 71.2
- Relative volume
- 1.29×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 126.6%
- Volatility vs own 5-year history
- 97th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.93
- Correlation with S&P 500
- 0.29
- Current drawdown from 1-year high
- +0.0%
- Maximum drawdown, 3 years
- -82.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 26, 2021 | Dec 17, 2025 | -88.5% | 1230 days | Not yet recovered |
| Oct 12, 2020 | Dec 21, 2020 | -35.5% | 49 days | 21 days (Jan 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $316.0M
- EPS, diluted (TTM)
- -$1.45
- Revenue (TTM)
- $75.6M
- 52-week range
- $3.22 – $12.76
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $33.0M | $34.4M | $50.1M | $64.3M | $71.6M |
| Gross profit | $26.9M | $28.4M | $42.4M | $55.2M | $58.8M |
| Operating income | -$25.1M | -$27.5M | -$42.7M | -$56.6M | -$42.5M |
| Net income | -$25.1M | -$26.7M | -$35.4M | -$61.8M | -$48.6M |
| EPS (diluted) | -$1.03 | -$1.07 | -$1.40 | -$2.39 | -$1.74 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.5M | $18.4M | $18.5M | $18.4M | $17.1M | $17.6M | $19.3M | $21.7M |
| Net income | -$16.2M | -$11.6M | -$13.9M | -$9.9M | -$13.2M | -$11.6M | -$10.6M | -$7.7M |
| EPS (diluted) | -$0.62 | -$0.44 | -$0.53 | -$0.38 | -$0.46 | -$0.38 | -$0.36 | -$0.25 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$18.0M | -$19.1M | -$38.0M | -$48.9M | -$31.2M |
| Capital expenditure | -$487,000 | -$525,000 | -$1.4M | -$9.3M | -$1.7M |
| Free cash flow | -$18.5M | -$19.6M | -$39.5M | -$58.3M | -$32.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $0 | $0 | $14.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $11.1M
- Total assets
- $47.8M
- Total liabilities
- $75.6M
- Total debt
- $48.5M
- Net debt
- $39.3M
- Shareholders’ equity
- -$27.8M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 2,885,693
- Days to cover
- 10.54
- Change vs previous report
- -1.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 30, 2020
- 1-for-5
- Oct 17, 2017
- 1,121-for-1,000
- Jun 21, 2016
- 1,013-for-1,000